Atlas Venture Fund Xi, L.P. Ikena Oncology, Inc. (IKNA) insider trading activity

Atlas Venture Fund Xi, L.P. is > 10% Shareholder of Ikena Oncology, Inc.. Currently has a direct ownership of 1.24 Million shares of IKNA, which is worth approximately $2.05 Million. The most recent transaction as insider was on Dec 14, 2021, when has been sold 5,959 shares (Common Stock) at a price of $14.0 per share, resulting in proceeds of $83,426. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.24M

0% 3M change

0% 12M change

Total Value Held $2.05 Million

Atlas Venture Fund XI, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 14 2021	SELL Open market or private sale	$83,426 $14.0 p/Share	5,959 Reduced 0.48%	1,241,935 Common Stock
Dec 13 2021	SELL Open market or private sale	$121,951 $14.64 p/Share	8,330 Reduced 0.66%	1,247,894 Common Stock
Dec 10 2021	SELL Open market or private sale	$180,195 $15.03 p/Share	11,989 Reduced 0.95%	1,256,224 Common Stock

Also insider at

DAWN

Day One Biopharmaceuticals, Inc. Healthcare

> 10% Shareholder

DYN

Dyne Therapeutics, Inc. Healthcare

XLO

Xilio Therapeutics, Inc. Healthcare

> 10% Shareholder

THRD

Third Harmonic Bio, Inc. Healthcare

> 10% Shareholder

AVF